Eric Foster

Eric has served as Ardelyx’s Chief Commercial Officer since August 2024. Before Ardelyx, Eric was a member of the executive team at Horizon Therapeutics, in the role of Senior Vice President and U.S. General Manager. Horizons was acquired by Amgen in October 2023.

Over the course of his career, Eric has garnered vast experience working across complex specialty and rare disease markets by implementing change management initiatives that drive growth in sales, marketing, and payor services. He has successfully provided strategic direction helping sales and marketing professionals to capitalize on untapped markets and revenue streams.

Prior to his time at Horizon Therapeutics, from 2010 to 2021, Eric held roles of increasing responsibility within the sales and marketing organization at GlaxoSmithKline across a variety of immunology and rare disease products, including serving as Vice President of Immunology Marketing, Senior Global Marketing Director and Field Sales Vice President. Eric began his career in sales and market access at Johnson & Johnson.
He previously served as a board member of the N.C. Arthritis Foundation and has been nominated for and received several leadership awards both inside and outside of the companies he has worked with.

Eric holds a Bachelor of Arts in Economics degree from the University of Georgia and a Master of Business Administration from Auburn University.

“Courage is what it takes to stand up and speak; courage is also what it takes to sit down and listen.”

– Winston Churchill